News

Zenith Healthcare Limited will hold a board meeting on Wednesday, October 28, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Ltd. The trading window for the company`s securities will remain closed until 48 hours after the financial results are declared.

Zenith Healthcare Limited informed the BSE that Bigshare Services Private Limited, the company`s Registrar and Share Transfer Agent (RTA) with SEBI registration number INR000001385, has confirmed receipt of no dematerialization requests for equity shares of Zenith Healthcare Limited from July 1, 2026, to September 30, 2026, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Zenith Healthcare Limited will close its trading window for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the announcement of its unaudited financial results for the quarter and half year ending September 30, 2026, in compliance with SEBI regulations.

Zenith Healthcare Limited informed the BSE Limited that Mr. Akshit M. Raycha (DIN: 03039859) has been regularized as Joint Managing Director/Whole Time Director at the company`s 32nd Annual General Meeting via a special resolution. The appointment, initially made on May 29, 2026, will continue until the conclusion of the next AGM, with a monthly remuneration of up to Rs 200,000, potentially increasing by Rs 900,000 per annum.

Zenith Healthcare Limited announced that Mr. Mahendra C. Raycha has been re-appointed as Managing Director for another three-year term, from July 1, 2026, to June 30, 2029, following a special resolution at the company’s 32nd Annual General Meeting. Mr. Raycha, who holds 6,604,000 equity shares, representing 12.29% voting power, was re-appointed due to attaining the age of 70 years, and his continued experience is deemed vital for the company`s future growth.